Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

“…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …”

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

“…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …”

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

“…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …”

Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease by Huashen Xu (13987046)

“…Especially, lead compounds <b>A1</b> and <b>A9</b> showed potent inhibitory activities against sEH (<b>A1</b> and <b>A9</b>; hsEH IC₅₀ = 0.1 nM, msEH IC₅₀ = 0.1 nM). …”

Decreased ratio of GSH/GSSG in <i>Slc1a1-</i>HET mice. by Parisa Afshari (4423141)

Vasopressin decreased the population fEPSP evoked by stimulation of LIII entorhinal fibers (EC LIII) and recorded in the CA2 dendritic field. by Magda Chafai (295116)

Microparticles Engineered to Highly Express Peroxisome Proliferator-Activated Receptor-γ Decreased Inflammatory Mediator Production and Increased Adhesion of Recipient Monocytes by Julie Sahler (666499)

IL-10^−/− mice develop a less severe PCM associated with increased cellular immunity that results in decreased mortality rates. by Tânia A. Costa (440296)

Bradykinin stimulation of PS-1 (M146L) AD fibroblasts results in decreased p38 activation relative to control fibroblasts. by Graziella Mendonsa (374346)

Inhibition of survivin decreased the expression of HIF-1α, TGF-β1 and TFE3 in human SACC-83 cell line. by Yu-Fan Wang (671665)

CAF induced proliferation and resistance to apoptosis, decreased PBMC adhesion and triggered <i>in vitro</i> angiogenesis of HUVECs cultured with uremic toxins. by Massimiliano Migliori (719107)

“…By contrast, increasing doses of CAF (100 nM, 1μM, 10μM) increased viabilty and resistance to apoptosis (*p < 0.05 Uremic Toxins + CAF 100 nM, 1μM or 10μM vs. …”

Effect of MI to decrease depressive symptoms (fixed-effects model). by Kalayou Kidanu Berhe (9557751)

Image_1_Reduced Ca2+ transient amplitudes may signify increased or decreased depolarization depending on the neuromodulatory signaling pathway.PDF by Arunima Debnath (13136676)

Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)

The Activation Effects of Low Level Isopropyl Alcohol Exposure on Arterial Blood Pressures Are Associated with Decreased 5-Hydroxyindole Acetic Acid in Urine by Zhiqiang Zhao (201543)

The GHS-R1A antagonist decreases saccharin intake in mice. by Sara Landgren (354407)

IgA is decreased in individual donor milk and is present in human milk-based fortifiers. by Christian Tamar (21100605)

DataSheet1_Solamargine Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma by Decreasing LncRNA HOXA11-As Expression.PDF by Ying Meng (327793)

Repeated Topical Administration of 3 nm Cerium Oxide Nanoparticles Reverts Disease Atrophic Phenotype and Arrests Neovascular Degeneration in AMD Mouse Models by Anna Badia (14322814)

Repeated Topical Administration of 3 nm Cerium Oxide Nanoparticles Reverts Disease Atrophic Phenotype and Arrests Neovascular Degeneration in AMD Mouse Models by Anna Badia (14322814)